<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01278472</url>
  </required_header>
  <id_info>
    <org_study_id>2010-0321/4</org_study_id>
    <nct_id>NCT01278472</nct_id>
  </id_info>
  <brief_title>Cosmesis and Body Image After Single Port or 4-Port Laparoscopic Cholecystectomy</brief_title>
  <official_title>Cosmesis and Body Image After Single Port Laparoscopic or Conventional Laparoscopic Cholecystectomy: A Double Blinded Randomised Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Laparoscopic Cholecystectomy (LC) is the treatment of choice for symptomatic gallstone
      disease. Single-port access cholecystectomy (SL) has been recently introduced using only one,
      trans-umbilical placed port. The method has been denominated as ''scarless.'' However, it is
      unknown whether SL significantly improves body and cosmesis images as well as the quality of
      life (QoL), reported directly by the patients. Furthermore SL promises to reduce
      postoperative pain and to be cost-effective due a faster postoperative recovery.

      The aim of this Double Blind Randomized Controlled Trial (RCT) is to demonstrate whether SL
      is superior to LC in improving patients', body and cosmesis images as well as QoL and to
      analyse cost-efficiency.

      Based on the sample size calculations, a total of 110 patients will be randomised to either
      LC or SL. The primary endpoint will be the cosmetic score. Costs, pain, time to
      convalescence, quality of life and complications and will also be compared as secondary
      endpoints.

      This study will provide evidence-based patient-oriented information regarding the SL
      procedure and its further use.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2011</start_date>
  <completion_date type="Anticipated">December 2012</completion_date>
  <primary_completion_date type="Anticipated">June 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cosmetic Score</measure>
    <time_frame>6 weeks postoperatively</time_frame>
    <description>validated score where the minimum is 3 and the maximum 24 points. A higher score signifies a greater satisfaction of the physical appearance of the scar</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body Image</measure>
    <time_frame>6 weeks postoperatively</time_frame>
    <description>validated score. A higher score signifies a better body image.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain</measure>
    <time_frame>up to 6 weeks postoperatively</time_frame>
    <description>Visual Analogue Scale</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Symptomatic Gallstone Disease</condition>
  <arm_group>
    <arm_group_label>Single Port Cholecystectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Laparoscopic Cholecystectomy with single port transumbilical access</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4 Port Cholecystectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Laparoscopic Cholecystectomy using 4 separate conventional trocars</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Single Port Cholecystectomy</intervention_name>
    <description>Using transumbilical single port device: SILS Port</description>
    <arm_group_label>Single Port Cholecystectomy</arm_group_label>
    <other_name>SILS PT5, Covidien Inc.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>4 Port Cholecystectomy</intervention_name>
    <description>using 4 separate skin incisions and 2 5mm and 2 12 mm conventional ports</description>
    <arm_group_label>4 Port Cholecystectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients above 18 years of age for elective cholecystectomy

          2. Written informed consent from the subject

          3. INR &lt; 1.4, platelet count &gt; 50'000/mcl

        Exclusion Criteria:

          1. Women in pregnancy

          2. Contraindications on ethical grounds

          3. Severe coagulopathy (platelet &lt; 50'000/mcl, double medication on platelet antagonists
             (Plavix and Aspirin), INR &gt; 1.4

          4. liver cirrhosis

          5. Enrolment of the investigator, his/her family members, employees and other dependent
             persons
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefan Breitenstein, PD, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Zurich</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stefan Breitenstein, PD, MD</last_name>
    <phone>044 255 33 00</phone>
    <email>stefan.breitenstein@usz.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Daniel C Steinemann, MD</last_name>
    <phone>044 255 92 84</phone>
    <email>daniel.steinemann@usz.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Zurich, Division of Visceral and Transplantation Surgery</name>
      <address>
        <city>Zurich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel C Steinemann, MD</last_name>
      <phone>044 255 92 84</phone>
      <email>daniel.steinemann@usz.ch</email>
    </contact>
    <investigator>
      <last_name>Stefan Breitenstein, PD, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Daniel C Steinemann, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <link>
    <url>http://www.vis.usz.ch</url>
    <description>University Hospital Zurich</description>
  </link>
  <verification_date>January 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 14, 2011</study_first_submitted>
  <study_first_submitted_qc>January 14, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 17, 2011</study_first_posted>
  <last_update_submitted>January 14, 2011</last_update_submitted>
  <last_update_submitted_qc>January 14, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 17, 2011</last_update_posted>
  <responsible_party>
    <name_title>PD Dr. med. Stefan Breitenstein</name_title>
    <organization>University Hospital Zurich, Division of Visceral and Transplantation Surgery</organization>
  </responsible_party>
  <keyword>cholecystectomy</keyword>
  <keyword>laparoscopic</keyword>
  <keyword>single-port</keyword>
  <keyword>gallstones</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gallstones</mesh_term>
    <mesh_term>Cholelithiasis</mesh_term>
    <mesh_term>Cholecystolithiasis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

